The integrity of endothelium-dependent vasodilation in the skin of patients with insulin-dependent diabetes mellitus (100M) is unclear, especially with respect to the role of nitric oxide. To examine this, forearm skin blood flow by laser Doppler ftowrnetrv and total blood flow by venous occlusion plethysmography was measured in response to brachial artery infusions of an endothelium-dependent (methacholine) and -independent (sodium nitroprusside) vasodilator. Peak hyperemic forearm blood flow, following 5 min of arterial occlusion, was also determined. Responses were compared in 11 control subjects and 16 patients with insulindependent diabetes mellitus.
Introduction
Peripheral vascular disease, renal disease with hypertension, and heart disease account for much of the morbidity and mortality associated with diabetes mellitus. The causes of the complications, however, are not clear but may involve disease of both the microvessels and macrovessels, I with insulin-dependent diabetes (IDDM) patients having a greater incidence of microvascular disease and non-insulindependent diabetes (NIDDM) patients having a higher occurrence of macrovascular disease associated with atherosclerosis.
The pathogenesis of chronic complications of diabetes © Arnold 1996 mellitus may result from impairment of endothelial function as shown in isolated macrovessels and microvessels from diabetic animals.' In fact, functional changes in the endothelium have been shown to occur in the aorta from genetically diabetic rats even before the levels of serum glucose are consistently elevated.' The endothelium plays an important role in the regulation of vascular tone and platelet function by producing relaxing and contracting factors. These include nitric oxide (NO), endothelium-derived hyperpolarizing factor, endothelin, prostacyclin, and vasoconstrictor prostanoids. There is evidence from experiments performed in vitro in isolated blood vessels (e.g. aorta) from diabetic animals," and in the penile smooth muscle from diabetic men with impotence," to suggest that endothelium-dependent vascular relaxations are impaired. Elevated levels of glucose may impair endothelium-dependent relaxation acutely by an increased production of vasoconstrictor prostanoids by the endothelium," by the generation of oxygen-derived free radicals.?" or chronically by quenching of NO by advanced glycosylation end-products.') for protein and ketones. Non-steroidal anti-inflammatory medication was not permitted for at least 4 days before the study and diabetic patients took their insulin as usual; no subjects or patients were taking vasoactive medications. Cigarette smoking was stopped on the night before the study.
Experimental protocol
Studies were performed in a temperature controlled laboratory. set at 2 I-22°C. with the subjects relaxed in the supine position. After 20 min equilibration, a 20-gauge catheter was placed into the brachial artery under sterile conditions after local anaesthesia with 2% lidocaine. The catheter was maintained patent by infusion of saline at 0.5 ml/min and was connected to a multiple channel stop-cock for infusions of L-NMMA (Clinalpha, Switzerland) and MCh chloride (Sigma) dissolved in 0.9% saline, and SNP (Abbott Laboratories) dissolved in 5% dextrose in water. Syringes containing SNP were protected from light exposure. The drugs were dissolved just before infusion and were administered using constant-infusion pumps (Harvard Apparatus Company). Intra-arterial blood pressure was measured continuously, via the brachial artery catheter, using a Hewlett-Packard pressure transducer (l280C). The mean blood pressure was calculated electronically. Skin blood flow (SkBF) was measured continuously using a laser Doppler flowmeter (LDF) (PF3; Perimed, Sweden). The probe was placed midway on the dorsal aspect of the forearm. Microvascular perfusion is measured by the LDF in approximately a 1 mm? hemispherical volume of tissue. The output signal, measured in units of voltage, is dependent on the number of moving blood cells multiplied by their average velocity in the volume of tissue sampled." Settings for the LDF were 4 kHz bandwidth and 0.2 s time constant. Biological zero was determined during arterial occlusion in all experiments and averaged 0.2 ± 0.04 (SEM) V. The biological zero was subtracted from the LDF readings of skin blood flow.
Forearm blood flow (FBF) was measured by venous occlusion plethysmography using a precalibrated mercuryin-silastic strain gauge positioned 4 ern below the elbow 
Methods
Although plasma levels of endothelial cell proteins have been used as evidence of endothelial damage, 10 .1 1 in vivo studies of endothelial dysfunction in patients with IDDM have produced inconsistent results, particularly with respect to the role of NO. 12 -16 Most of these studies used methodology which did not differentiate skin from muscle blood flow. Because these two vascular beds differ in their responses. this could explain the inconsistent results. It is important to assess the skin circulation in patients with diabetes since they are prone to ulcerations, infections. and trophic changes. It has been reported that there is an impairment of capillary blood flow in the nailfold of the toes by capillaroscopy in patients with IDDM and no late complications, but the blood flow measured by laser Doppler fluxmetry was normal," possibly due to blood flow through the arteriovenous anastomoses. Another investigation reported a reduced postischemic hyperemia in children with IDDM, but blood flow was measured by transcutaneous oxygen tension which may be more reflective of tissue metabolism than of vascular reactivity in IDDM. 18 In the present study. we measured the responses to intraarterial infusions of methacholine (MCh) and sodium nitroprusside (SNP), which are endothelium-dependent and -independent vasodilators respectively, in an area devoid of arteriovenous anastomoses, the forearm skin of patients with IDDM. Results from a recent study investigating the characteristics of vasodilating muscarinic-receptor subtypes in humans'? suggest that a stable cholinergic agonist. such as MCh. is more appropriate than acetylcholine for clinical studies because it is more resistant to breakdown by acetylcholinesterase. Rongen et al,20 however. suggest that NO does not contribute significantly to MChinduced forearm vasodilation and. therefore. we also examined the effect of NG-monomethyl-L-arginine (L-NMMA), an inhibitor of NO production, on MCh-induced vascular responses.
Patients and subjects
All studies were performed under the approval of the Institutional Review Board for Human Studies and all participants gave written informed consent. Sixteen patients with IDDM and 20 non-diabetic healthy control subjects were enrolled. Ten control subjects (five male, five female) with an average age of 25 (range 20-38) years were used to examine the effects of L-NMMA on blood flow. Eleven subjects were used as controls to compare blood flow responses with those from diabetic patients ( Table I) . None of the diabetic patients had evidence of hypertension. hypercholesterolemia. retinopathy or overt atherosclerosis as judged by the absence of cerebrovascular ischemia, claudication or angina. Peripheral pulses were normal on palpation. Autonomic and sensory nerve function were determined by clinical examination. Vibration perception was determined at the ankle and great toes using a tuning fork. Six patients had decreased vibratory sense. eight had decreased reflexes and three had evidence of autonomic neuropathy. determined by cardiovascular function tests. Vibration perception, reflexes and autonomic function were all normal in eight patients. Urine samples were negative Table I shows the baseline clinical characteristics of the diabetic patients and control subjects. There were no significant differences in age, blood pressure, heart rate, or total cholesterol between the two groups. HDL cholesterol values were, however, significantly lower in the diahetic group (p<O.005).
Results

Effects of L·NMMA on basal blood flow and MCh· induced vasodilation in normal subjects
Basal SkBF significantly decreased hy 32 f Jf, during infusion of L-NMMA (8 urn/min) ( Table 2 ). L-NMMA (8 urn/min) produced a 27% reduction in basal FBF (p <0.005) and a 40% fall in FVC (p<O.OO I). Infusion of L-NMMA increased blood pressure by 8% (78±3 to 84±3 mmHg, p<0.05). 
Statistics
Data are expressed as mean±SEM. Differences in SkBF, FBF, and FVC dose-response curves were determined by ANOV A of independent groups for repeated measures followed by r-tests, The significance of differences hetween groups was determined by the r-test for unpaired data. Correlations were performed using Pearson's correlation. The null hypothesis was rejected at p<O.05. joint." Venous occlusion was produced using a pneumatic cuff placed around the upper arm. The hand circulation was excluded during measurements of FBF by placing a cuff around the wrist and inflating it to 200 mmHg. The venous occlusion pressure was determined for each subject as the lowest pressure (usually 35-45 mmHg) required to produce the maximum rate of increase in the volume of the forearm. FBF was calculated in units of mllmin/100 ml tissue. Forearm vascular conductance (FVC) was calculated by dividing the average measurement of FBF by the mean arterial pressure and is expressed in units of mllmin/I00 ml tissue/mmHg.
After a further 15-min equilibration period, baseline SkBF was continuously recorded; FBF measurements were made every 30 s during infusion of saline and were averaged over a period of 10 min. On one occasion, in ten control subjects, the effect of NO inhibition on basal SkBF and FBF was examined during infusions of L-NMMA (8 urn/min) for 4 min each. Measurements of FBF were made every 30 s and the last 2 min of measurements were used for subsequent analyses. On another occasion, MCh was infused in doses of 0.3 and 3.0 ug/rnin for 4 min each. At the end of this period, normal saline was infused continuously and. once blood flow had returned to baseline, L-NMMA (8 urn/min) was infused for 4 min. MCh (0.3 and 3.0 ug/min) was then infused with the L-NMMA to assess the contribution of NO to MCh-induced vasodilation.
The following experiments were conducted on separate occasions from those above. Endothelium-dependent vasodilator responses were measured during infusion of increasing doses of MCh (0.03, 0.3, 3 and 10 u.g/min) for 4 min each. After the last dose of MCh, saline was infused until SkBF and FBF returned to baseline. To ensure that changes in SKBF were not due to any non-specific effects of the experimental procedure, 0.9% saline was infused for three periods of 4 min each in three control subjects and three diabetic patients to mimic the procedure for infusions of
Meh.
To measure endothelium-independent vasodilator responses, SNP was infused in increasing doses (0.03, 0.3, 3 and 10 ug/min) for 4 min each. At the end of this infusion period. baseline SkBF and FBF were re-established before the upper arm cuff was inflated to 200 mmHg, for 5 min, to produce an ischemic stimulus. During the last 2 min of ischemia. the forearm was exercised by repetitive hand squeezing of a gauze roll. On release of the cuff, the subsequent reactive hyperemia was measured over 2 min.
At the end of the study, a sample of blood was withdrawn from the brachial artery for measurement of blood glucose, using an Accuchek II monitor (Boehringer, Mannheim), and plasma cholesterol levels. of FBF (p<0.002) and FVC (p<O.OOl) to MCh (Figure 2) . At the largest dose of MCh (3 ug/min), the response of FBF was reduced only by 22% and FVC by 30% during co-infusion of L-NMMA.
Effects of MCh, SNP, and ischemia on skin blood flow
There were no significant differences in the change in SkBF, as measured by the LDF, between the control subjects and diabetic patients in response to increasing doses of MCh or SNP (Figure 3 ). During infusion of MCh at to f.Lglmin, there was a significant fall in mean arterial blood pressure from basal values in control subjects (81±2 to 78±2 mmHg, p<0.05) and in diabetic patients (87±3 to 83±3 mmHg, p<O.Ol). There was, however, no significant difference in the change in blood pressure between the two groups. Heart rate did not change significantly during infusion of MCh in either group. At the end of the infusion of MCh, blood flow returned to basal levels within 20 min. There was no change in SkBF during infusion of 0.9% saline for three periods of 4 min each in the three control subjects and three diabetic patients examined. SNP had a relatively small effect on SkBF in both control subjects and diabetic patients (Figure 3 ). At the highest dose of SNP (to f.Lg/min), there was an increase in SkBF of only 80±25% and 130±25%, respectively. In fact, in one control subject and two diabetic patients, SNP had no effect on SkBF at all. In contrast, at the highest dose of MCh, there was an increase in SkBF of 291±112% and 404±62% in control subjects and diabetic patients, respectively, and all Figure 3 Laser Doppler measurements of skin blood flow during intra-arterial infusions of (a) methacholine and (b) sodium nitroprusside in control subjects (n=11) and diabetic patients (n=16). Changes in skin blood flow are expressed as a percentage of the basal value. There were no significant differences in the dose-response curves between the groups. subjects responded. There was a significant fall in mean arterial blood pressure at the highest dose of SNP (10 ug/min), 84±2 to 78±3 mmHg (p<0.05) in control subjects and 88±3 to 84±3 mmHg in diabetic patients (p<0.OO5), but there was no significant difference in the change in blood pressure between the two groups. There was no significant change in heart rate with SNP in either group of subjects.
Peak reactive hyperemic blood flow in the skin was not significantly different between the control and diabetic group; the percentage change in SkBF from basal values was 283% and 243%, respectively. 
Effects of MCh, SNP, and ischemia on total forearm blood flow
Basal FBF and FVC before infusion of MCh and SNP were similar in control subjects and diabetic patients (Figures 4  and 5 ). Intra-arterial infusions of increasing doses of MCh produced an increase in FBF and FVC from basal levels in control subjects and diabetic patients. Figure 4 illustrates that there were no significant differences in the magnitude of change in FBF and FVC between the two groups. The peak FBF in control subjects and diabetic patients was 25.0±3.4 and 24.2±2.1 ml/min/IOO ml tissue, respectively; peak FVC was 0.32±O.04 and 0.30±0.02 units, respectively.
Infusion of increasing doses of SNP resulted in an increase in FBF and FVC from basal values. The magnitude thelium-derived nitric oxid e (NO) is continuously relea sed in the maintenance of vascular tone." We have reported similar findings for finger and forearm skin blood flow previously." These results confirm in man the finding that NO participates in the regulation of skin blood now in the rubhit ear." Other investigators have shown a decrease in basal total forearm blood flow with L-NMMA in patients with IDDM. 13 . 15 However. the decrease caused by L-NMMA was less in diabetic patients compared to normal subjects. but one group found this only in patients with microalbuminuria." We found no significant differences in the of the dose-related increase in FBF and FVC was reduced significantly in the diabetic group compared with the response in the control group (p<0.OO5 for FBF and FVC; Figure 5 ). In the control group, the peak FBF (23.2±3.8 mllminllOO ml tissue) and FVC (0.3I±O.06 units) were of a similar magnitude to the peak responses to MCh . In contrast, in the diabetic group. peak responses were significantly less for SNP than for MCh (FBF=14.5 ± 1.2 ml/minllOO ml tissue. p<O.OOI;
FVC=0.18 ± 0.02 units. p<O.OO I).
Peak reactive hyperemic forearm blood flow, following a 5-min ischemic stimulus with exercise, was also reduced significantly in the diabetic group, by 30% compared with the response in control subjects (p<0 .05; Figure 6 ). Thi s reduction in peak FBF was of a similar magnitude as the reduction in FBF at the highest dose of SNP (10 ug/min).
There was no significant relationship between the blood flow response to MCh or SNP and age. smoking, duration of diabetes (range 0.5-23 years), blood glucose level . dosage of insulin or HbA Ic values. Neither was there any significant correlation between the blood flow responses and any of the other clinical parameters shown in Table I for either group.
The reduction in skin blood flow during infusions of L-NMMA in normal subjects supports the concept that endo-Discussion skin blood flow responses to MCh, SNP, and an ischemic stimulus of patients with IDDM from normal subjects. Others have reported an impairment of the reactive hyperemia response in the nailfold of the toes in addition to a reduced capillary blood flow." This is evidently not a generalized defect since the forearm skin did not show decreased capillary or reactive hyperemic blood flow. Reactive hyperemic blood flow by laser Doppler fluxmetry was only found to be decreased in IDDM patients with incipient nephropathy by Houben et aF6. There does not therefore appear to be any abnormality in the release of endothelialderived relaxing factor or the response to NO in the cutaneous circulation of patients with IDDM without complications to explain their predisposition to skin breakdown or increased blood flow. The relatively small vasodilator response to SNP in both groups is consistent with our previous report'? and Warren's findings with local injections."
The lack of an inhibitory effect of L-NMMA on the MChinduced increases in skin blood flow suggests that NO does not contribute significantly to this response in the cutaneous circulation. Warren showed, however, that L-NMMA, but not indomethacin, locally injected into forearm skin significantly reduced the local vasodilation to acetylcholine." In skin, NO may contribute differently to MCh-and acetylcholine-induced vasodilation, perhaps because of the different action of the two agents on muscarinic receptors" or their different susceptibility to acetylcholinesterase.
Total forearm blood flow responses (plethysmography) to MCh were similar in patients with IDDM and in control subjects, but impaired vasodilation occurred to SNP and an ischemic stimulus. The abnormal response must be characteristic of blood vessels of the forearm skeletal muscle because laser Doppler measurements of forearm skin blood flow did not show this abnormality. The literature is controversial regarding forearm endothelial vasodilator responses in IDDM patients. Calver et al!' found a normal vasodilation to acetylcholine and a reduced response to SNP in patients with IDDM, which agrees with our results. Other investigators, however, have found normal vasodilatory responses to the muscarinic agonist carbachol, 12 SNP, 12.14.16 or an ischemic stimulus.":" An abnormal response to MCh was reported by Johnstone. et al." perhaps due to pretreatment with aspirin blocking prostaglandins. It is difficult to reconcile the different findings of these studies since the study patients often were similar in respect to the duration and severity of diabetes and the extent of complications.
The reason for a normal total forearm blood flow response to MCh but a reduced response to SNP in the diabetic group in this study is unclear. The latter could be due to a defect in the vascular response to NO, the degradation product of SNP, but this would not explain the normal response to MCh. It is possible that stimulation of muscarinic receptors on blood vessels of the forearm may result in the production of other endothelium-derived factors unrelated to NO, which may give rise to the normal vasodilator response to MCh in IDDM patients. Vallance et alB showed that L-NMMA infused into the brachial artery of normal human subjects did not inhibit completely the vasodilator response to acetylcholine. Similarly, we found that L-NMMA inhibited MCh-induced vasodilation by only 30%, indicating that NO-independent mechanisms may playa role or that the inhibition is incomplete. Further evidence to support the concept that endothelium-dependent, Vascular Medicine 1996; 1: [187] [188] [189] [190] [191] [192] [193] NO-independent vasodilation to muscarinic agonists may be enhanced in patients with IDDM was provided by Elliott et al." They demonstrated that, while IDDM patients with microalbuminuria had similar vascular responses to the muscarinic agonist carbachol as those in control subjects, the contribution of NO to the increase in forearm blood flow was small since L-NMMA had no significant inhibitory effect in IDDM patients but did in control subjects. Unfortunately, we were not able to measure microalbuminuria in the patients in our study but eight of 16 patients had evidence of neuropathy.
SNP causes vasodilation by a NO-induced increase in cyclic GMP production which is mediated by an increase in the activity of soluble guanylate cyclase." The ability of NO to cause vascular relaxation may be diminished by the generation of superoxide anions, as shown in vitro in the aorta of rabbits.v-" Levels of free radical products have previously been found to be elevated and free radical scavenging enzymes to be reduced in patients with diabetes mellitus." which might explain a reduced response to SNP.
Stimulation of guanylate cyclase is dependent upon an enzymatic conversion of organic nitrates by intracellular thiol-containing compounds. The increased oxidative stress that occurs in diabetes could alter the equilibrium of intracellular thiols, leading to a decrease in their levels and rendering the vasculature insensitive to organic nitrates.r' Alternatively, NO might be quenched by advanced glycosylation end-products, leading to inhibited responses to SNP,9 Similarly, if NO is involved in the ischemic response in the forearm, as it is in part in the cat hindlimb" and in the human myocardium," then an impairment in the response of blood vessels to NO may explain the reduced hyperemia in the diabetic group.
It is concluded that the skin circulation of the forearm of patients with IDDM and no macrovascular disease shows a normal response to a muscarinic receptor agonist, a NO donor, and an ischemic stimulus. Abnormalities of forearm blood flow responses found in this study and other investigations must therefore be present in the muscle vasculature.
